Olaparib and Temozolomide in Treating Patients With Relapsed Glioblastoma

Clinical trial NCT01390571 · COMPLETED

Trial details

NCT number: NCT01390571
Sponsor: Cancer Research UK
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Brain and Central Nervous System Tumors

Start date: 2011-07-01
Primary completion: 2017-06-20
Enrollment: 34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.